Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × enzalutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 91 Prostatic Neoplasms, Castration-Resistant 11 Neoplasm Metastasis 8 Neoplasms 7 Breast Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Metastatic Castration-Resistant Prostate Cancer 3 Melanoma 3 mCRPC 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostate Adenocarcinoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Metastatic Hormone-sensitive Prostate Cancer 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Bulbo-Spinal Atrophy, X-Linked 2 Bites and Stings 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1

Interventions

Gemcitabine 19 Mitomycin 9 Docetaxel 7 erdafitinib 5 BCG Vaccine 5 durvalumab 4 dodecyl maltoside 4 Cystoscopy 4 Radiotherapy 3 ALT-803 3 5-aminolevulinic acid hexyl ester 2 viscum album peptide 1 tremelimumab 1 toripalimab 1 pirarubicin 1 pemigatinib 1 monalizumab 1 hydroxycamptothecinum 1 enfortumab vedotin 1 chondroitin sulfate, sodium hyaluronate drug combination 1 bicalutamide 1 Urine Specimen Collection 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Patient Discharge 1 Paclitaxel 1 Nonsteroidal Anti-Androgens 1 Mitozytrex 1 Maintenance 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡